TITLE

α1-Antitrypsin: more than just deficiency

AUTHOR(S)
Stockley, R. A.
PUB. DATE
May 2004
SOURCE
Thorax;May2004, Vol. 59 Issue 5, p363
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Abnormal levels of α 1-antitrypsin represent a syndrome of clinical disease entities, some relating to a deficiency while others reflect an overload. With growing interest in the genetic nature of diseases and the clinical disorders associated with antitrypsin abnormalities, many countries developed national registries. This has resulted in the discovery of other clinical conditions that are more frequent in individuals with Pi ZZ antitrypsin, including vasculitis, Wegner's granulomatosis, glomerulonephritis and panniculitis. Thus the condition is associated with many clinical disease entities and is more representative of a syndrome.
ACCESSION #
13372496

 

Related Articles

  • Association of α1-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis. Mahadeva, R.; Sharples, L.; Ross-Russell, R. I.; Webb, A. K.; Bilton, D.; Lomas, D. A. // Thorax;Jan2001, Vol. 56 Issue 1, p53 

    Background -- Cystic fibrosis (CF) is characterized by an excess of free proteinases that destroy lung tissue. Despite this, previous studies have shown that patients with CF with a mild deficiency variant of the proteinase inhibitor α1-antitrypsin have less, rather than more, severe...

  • Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin--related liver disease in mice. Shuling Guo; Booten, Sheri L.; Aghajan, Mariam; Gene Hung; Chenguang Zhao; Blomenkamp, Keith; Gattis, Danielle; Watt, ANdrew; Freier, Susan M.; Teckman, Jeffery H.; McCaleb, Michael L.; Monia, Brett P. // Journal of Clinical Investigation;Jan2014, Vol. 124 Issue 1, p251 

    Alpha-1 antitrypsin deficiency (AATD) is a rare genetic disease that results from mutations in the alpha-1 antitrypsin (AAT) gene. The mutant AAT protein aggregates and accumulates in the liver leading to AATD liver disease, which is only treatable by liver transplant. The PiZ transgenic mouse...

  • Discovery of an Inhibitor of Z-Alpha1 Antitrypsin Polymerization. Berthelier, Valerie; Harris, Jason Brett; Estenson, Kasey Noel; Baudry, Jerome // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Polymerization of the Z variant alpha-1-antitrypsin (Z-α1AT) results in the most common and severe form of α1AT deficiency (α1ATD), a debilitating genetic disorder whose clinical manifestations range from asymptomatic to fatal liver and/or lung disease. As the altered conformation of...

  • The effect of avian blood on Leishmania development in Phlebotomus duboscqi. Pruzinova, Katerina; Votypka, Jan; Volf, Petr // Parasites & Vectors;2013, Vol. 6 Issue 1, p1 

    Background: The development of pathogens transmitted by haematophagous invertebrate vectors is closely connected with the digestion of bloodmeals and is thus affected by midgut enzymatic activity. Some studies have demonstrated that avian blood inhibits Leishmania major infection in the Old...

  • 71. Alpha 1 Antitrypsin (AAT) Gene Therapy for the Prevention of Type 1 Diabetes*. Song, Sihong; Lu, Yuanqing; Tang, Mei; Zhang, Bin; Wasserfall, Clive; Campbell-Thompson, Martha; Atkinson, Mark // Molecular Therapy;Jun2006, Vol. 13, pS30 

    Type 1 diabetes is an autoimmune disease that results in the destruction of insulin producing b cells in the pancreatic islets. Although multiple factors contribute to this disease, an imbalance of the immune regulatory pathways plays an important role in the development of type 1 diabetes....

  • Outcome of PiSS and PiSZ alpha-1-antitrypsin deficiency presenting with liver involvement. Hadzic, Nedim; Francavilla, Ruggiero; Chambers, Susan M.; Castellaneta, Stefania; Portmann, Bernard; Mieli-Vergani, Giorgina // European Journal of Pediatrics;Apr2005, Vol. 164 Issue 4, p250 

    Examines the outcome of PiSS and PiSZ alpha-1-antitrypsin deficiency (A1ATD) presenting with liver involvement in children. Charcteristics of A1ATD; Putative pathogenic mechanism for the liver disease in PiZZ A1ATD; Subjects of the study.

  • α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. Bergin, David A.; Reeves, Emer P.; Meleady, Paula; Henry, Michael; McElvaney, Oliver J.; Carroll, Tomás P.; Condron, Claire; Chotirmall, Sanjay H.; Clynes, Martin; O'Neill, Shane J.; McElvaney, Noel G.; Carroll, Tomás P // Journal of Clinical Investigation;Dec2010, Vol. 120 Issue 12, p4236 

    Hereditary deficiency of the protein α-1 antitrypsin (AAT) causes a chronic lung disease in humans that is characterized by excessive mobilization of neutrophils into the lung. However, the reason for the increased neutrophil burden has not been fully elucidated. In this study we have...

  • Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction. Sandford, A. J.; Silverman, E. K. // Thorax;Aug2002, Vol. 57 Issue 8, p736 

    Genetic factors including alpha(1)-antitrypsin deficiency are important in COPD. Candidate gene association studies in COPD are reviewed. Efforts to identify interactions between genetic factors and environmental determinants such as smoking may lead to improved understanding of the pathogenesis...

  • University College London Collaboration Aims to Treat Alpha-1-Antitrypsin Deficiency (Case study). Lomas, David // International Labmate;Apr2014, Vol. 39 Issue 3, p52 

    The article presents a case study of treating Alpha-1 antitrypsin deficiency.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics